The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (EAP).
 
Deniz Tural
No Relationships to Disclose
 
Oguzcan Özkan
No Relationships to Disclose
 
Sendag Yaslikaya
No Relationships to Disclose
 
Ali Tatli
No Relationships to Disclose
 
Goncagül Akdag
No Relationships to Disclose
 
Hacer Demir
No Relationships to Disclose
 
Irem Bilgetekin
No Relationships to Disclose
 
Fatih Selcukbiricik
No Relationships to Disclose
 
Fatih Köse
No Relationships to Disclose
 
Murat Sari
No Relationships to Disclose
 
Gökmen Erdem
No Relationships to Disclose
 
Zehra Sucuoglu Isleyen
No Relationships to Disclose
 
Cagatay Arslan
Consulting or Advisory Role - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Speakers' Bureau - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Research Funding - Roche, Novartis, BMS, Merck, MSD, Astra Zeneca, Nektar, Johnson &Johnson, Lilly, Amgen, Incyte, Bayer, Yuhan, Henlius, Pfizer, Biontech, Genmab, Beigene, GSK
 
Sinemis Celik
No Relationships to Disclose
 
Türkan Evrensel
No Relationships to Disclose
 
Mustafa Erman
No Relationships to Disclose
 
Seher Kazaz
No Relationships to Disclose
 
Banu Ozturk
No Relationships to Disclose
 
Caner Kapar
No Relationships to Disclose
 
Yüksel Ürün
Honoraria - Abdi Ibrahim; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Gilead Sciences; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abdi Ibrahim; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Gilead Sciences; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Abdi Ibrahim; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Janssen; Merck Serono; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Abdi Ibrahim; Bristol-Myers Squibb; Eczacibasi; Gen Ilaç; Pfizer; Roche